Psychedelic drug DMT to be trialled in UK to treat depression

From The Guardian: “UK regulators have given the go-ahead for the first clinical trial of the use of the psychedelic drug dimethyltriptamine (DMT) to treat depression. The trial will initially give the drug – known as the “spirit molecule” for the powerful hallucinogenic trips it induces – to healthy individuals, but it is expected to be followed by a second trial in patients with depression, where DMT will be given alongside psychotherapy…”

DMT, PoliticalArtful AlchemyDecember 10, 2020DMT, DMT Trials, Depression, Psychedelics, Therapy, Entheogens, Imperial College, United Kingdom, legalisation, Laws

Imperial College London Launches World’s First Centre for Psychedelics Research

“The first formal centre for psychedelic research in the world will launch at Imperial College London today. Funded by more than £3 million from five founding donors, the new Imperial Centre for Psychedelic Research will build on over a decade of pioneering work in this area carried out at Imperial, including a clinical trial that has kick-started global efforts to develop psilocybin therapy into a licensed treatment for depression…”

PsychedelicsArtful AlchemyApril 26, 2019Research, Psychedelics, Psilocybin, Consciousness, Laws, Neuroscience, Depression, Mental Illness, Health, Therapy, United Kingdom, PTSD, LSD, DMT, MDMA